Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NK Cell-Based Immune Checkpoint Inhibition
Muhammad Khan, Sumbal Arooj, Hua Wang
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 276

Showing 1-25 of 276 citing articles:

Exploring the NK cell platform for cancer immunotherapy
Jacob A. Myers, Jeffrey S. Miller
Nature Reviews Clinical Oncology (2020) Vol. 18, Iss. 2, pp. 85-100
Open Access | Times Cited: 908
Radiotherapy combined with immunotherapy: the dawn of cancer treatment
Zengfu Zhang, Xu Liu, Dawei Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 344
The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy
Vincenzo Salemme, Giorgia Centonze, Federica Cavallo, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 182
Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial
Jamie E. Chaft, Filiz Öezkan, Mark G. Kris, et al.
Nature Medicine (2022) Vol. 28, Iss. 10, pp. 2155-2161
Open Access | Times Cited: 163
Flattening the COVID-19 Curve With Natural Killer Cell Based Immunotherapies
Marisa Market, Leonard Angka, Andre B. Martel, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 145
Dual Effect of Immune Cells within Tumour Microenvironment: Pro- and Anti-Tumour Effects and Their Triggers
Alicia Cristina Peña-Romero, Esteban Orenes‐Piñero
Cancers (2022) Vol. 14, Iss. 7, pp. 1681-1681
Open Access | Times Cited: 144
NK cell infiltration is associated with improved overall survival in solid cancers: A systematic review and meta-analysis
Sarah Nersesian, Sarah L. Schwartz, Stephanie R. Grantham, et al.
Translational Oncology (2020) Vol. 14, Iss. 1, pp. 100930-100930
Open Access | Times Cited: 142
Natural killer cell therapies
Éric Vivier, Lucas Rebuffet, Émilie Narni-Mancinelli, et al.
Nature (2024) Vol. 626, Iss. 8000, pp. 727-736
Closed Access | Times Cited: 134
Exploiting innate immunity for cancer immunotherapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 78
NK cells are never alone: crosstalk and communication in tumour microenvironments
Yongqiang Zhou, Cheng Lu, Lu Liu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 75
Novel targets for immune-checkpoint inhibition in cancer
Maxime Borgeaud, José Luís Sandoval, Michel Obéid, et al.
Cancer Treatment Reviews (2023) Vol. 120, pp. 102614-102614
Open Access | Times Cited: 52
Diversity of immune checkpoints in cancer immunotherapy
Zhangyan Guo, Rui Zhang, Angang Yang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 44
CAR-NK cells for cancer immunotherapy: recent advances and future directions
Tianye Li, Mengke Niu, Weijiang Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 23
Engineering immune-evasive allogeneic cellular immunotherapies
Karen E. Martin, Quirin Hammer, Karlo Perica, et al.
Nature reviews. Immunology (2024) Vol. 24, Iss. 9, pp. 680-693
Closed Access | Times Cited: 16
Soluble PD-1: Predictive, Prognostic, and Therapeutic Value for Cancer Immunotherapy
Muhammad Khan, Zhihong Zhao, Sumbal Arooj, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 128
Immune checkpoint molecules in natural killer cells as potential targets for cancer immunotherapy
Yuqing Cao, Xiaoyu Wang, Tianqiang Jin, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 120
CAR-NK Cells: From Natural Basis to Design for Kill
Muhammad Babar Khawar, Haibo Sun
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 95
Natural killer cell-based immunotherapy for acute myeloid leukemia
Jing Xu, Ting Niu
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 87
Fibrinogen-like protein 1 (FGL1): the next immune checkpoint target
Wenjing Qian, Mingfang Zhao, Ruoyu Wang, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 78
Inhibitory Receptors and Checkpoints in Human NK Cells, Implications for the Immunotherapy of Cancer
Simona Sivori, Mariella Della Chiesa, Simona Carlomagno, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 76
Natural Killer Cell Interactions With Myeloid Derived Suppressor Cells in the Tumor Microenvironment and Implications for Cancer Immunotherapy
Cristina Zalfa, Silke Paust
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 71
Reprogramming the tumor microenvironment by genome editing for precision cancer therapy
Ke Liu, Jiajia Cui, Yan Zhan, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 66
Blockade of novel immune checkpoints and new therapeutic combinations to boost antitumor immunity
Adrià Archilla‐Ortega, Carla Domuro, Juan Martín-Liberal, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 63
Chimeric Antigen Receptor-Engineered Natural Killer (CAR NK) Cells in Cancer Treatment; Recent Advances and Future Prospects
Reza Elahi, Amir Hossein Heidary, Kaveh Hadiloo, et al.
Stem Cell Reviews and Reports (2021) Vol. 17, Iss. 6, pp. 2081-2106
Open Access | Times Cited: 62
Current insight into the regulation of PD-L1 in cancer
Zhuandi Liu, Xibao Yu, Ling Xu, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 61
Page 1 - Next Page

Scroll to top